Clinical Trials
2
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
PK and Safety Study of Natroba Topical Suspension 0.9% in Subjects 1 Month to 3 Years 11 Months of Age with Scabies
- First Posted Date
- 2022-04-05
- Last Posted Date
- 2025-02-14
- Lead Sponsor
- Cipher Pharmaceuticals Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT05310734
- Locations
- 🇺🇸
L&C Professional Medical Research Institute, Miami, Florida, United States
🇺🇸Velocity Clinical Research, Lafayette, Louisiana, United States
🇺🇸Elixir Research Group, Houston, Texas, United States
Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne
- First Posted Date
- 2009-09-11
- Last Posted Date
- 2014-07-04
- Lead Sponsor
- Cipher Pharmaceuticals Inc.
- Target Recruit Count
- 925
- Registration Number
- NCT00975143
- Locations
- 🇺🇸
Total Skin & Beauty Dermatology Center, Birmingham, Alabama, United States
🇺🇸Burke Pharmaceutical Research, Hot Springs, Arkansas, United States
🇺🇸Center for Dermatology Clinical Research, Fremont, California, United States
News
Moberg Pharma's MOB-015 Phase 3 Trial Shows Lower Than Expected Clinical Cure Rate
Moberg Pharma reports that a subset of patients in their North American Phase 3 study of MOB-015 achieved clinical cure for nail fungus at a rate lower than anticipated.